Powder for external use for treating upper respiratory infection

A powder for external use and upper respiratory tract technology, which is applied in the field of medicine, can solve the problems of not obvious curative effect and slow effect, and achieve the effect of accelerating wound healing, lasting drug effect and ensuring effective utilization rate

Inactive Publication Date: 2015-01-07
徐会作
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Therefore, the general clinical treatment principle is local treatment, anti-inflammation with antibiotics, atomization or fumigation treatment, or conditioning with traditional Chinese medicine, but the curative effect is not obvious and the effect is slow.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0020] An external powder for treating upper respiratory tract infection, comprising the following components:

[0021] Nano silver 1g, pearl powder 1g, sulfur 2g, aloe vera 2g, light powder 1g;

[0022] The particle diameter of the nano-silver is 25nm.

[0023] The preparation method of the present invention comprises the following steps:

[0024] Step 1: Sulfur, aloe and light powder are pulverized with an ultrafine pulverizer, and passed through a 200-mesh sieve to obtain component A;

[0025] Step 2: Mix the nano-silver, pearl powder and the component A with a mixer for 1 hour to obtain the mixed medicine;

[0026] Step 3: Fill the mixed drug into the nanocloth, and finally pack the nanocloth containing the mixed drug to obtain a finished product.

experiment example 2

[0028] An external powder for treating upper respiratory tract infection, comprising the following components:

[0029] Nano silver 2g, pearl powder 2g, sulfur 2g, aloe vera 2g, light powder 5g;

[0030] The particle size of the nano-silver is 30nm.

[0031] The preparation method of the present invention comprises the following steps:

[0032] Step 1: Sulfur, aloe and light powder are pulverized with an ultrafine pulverizer, and passed through a 200-mesh sieve to obtain component A;

[0033] Step 2: Mix the nano-silver, pearl powder and the component A with a mixer for 0.20 hours to obtain the mixed medicine;

[0034] Step 3: Fill the mixed drug into the nanocloth, and finally pack the nanocloth containing the mixed drug to obtain a finished product.

experiment example 3

[0036] An external powder for treating upper respiratory tract infection, comprising the following components:

[0037] Nano silver 20g, pearl powder 3g, sulfur 3g, aloe vera 15g, light powder 2g;

[0038] The particle diameter of the nano-silver is 40nm.

[0039] The preparation method of the present invention comprises the following steps:

[0040] Step 1: Sulfur, aloe and light powder are pulverized with an ultrafine pulverizer, and passed through a 200-mesh sieve to obtain component A;

[0041] Step 2: Mix the nano-silver, pearl powder and the component A with a mixer for 2 hours to obtain the mixed medicine;

[0042] Step 3: Fill the mixed drug into the nanocloth, and finally pack the nanocloth containing the mixed drug to obtain a finished product.

[0043] The therapeutic effect of the present invention on treating pharyngitis of upper respiratory tract infection is further illustrated below through clinical application.

[0044] According to the theory of tradition...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a powder for external use for treating upper respiratory infection. The powder for external use comprises the following components: nano silver, pearl powder, sulphur, aloe and calomel. The powder for external use is safe and efficient, has broad-spectrum antimicrobial treatment effects and can quickly infiltrate the skin to reach a target part, thereby achieving a sterilization function. The powder for external use takes the nano silver and pearl powder as main drugs, and further comprises the sulphur, the aloe and the calomel, so that the effects are remarkable, the drug effect is lasting; through the adoption of the nano silver, the drug resistance is avoided, and the toxic or side effects and irritating allergic phenomena are avoided.

Description

technical field [0001] The invention relates to a medicine, in particular to an external powder for treating upper respiratory tract infection. Background technique [0002] Upper respiratory tract infection is a general term including acute inflammation of the nasal cavity, pharynx or larynx, with a relatively high incidence. Adults occur 2 to 4 times a year, and children have a higher incidence of 6 to 8 times a year. All can fall ill throughout the year, more in winter and spring. [0003] 70% to 80% of upper respiratory tract infections are caused by viruses. Includes rhinoviruses, coronaviruses, adenoviruses, influenza and parainfluenza viruses, respiratory syncytial virus, echoviruses, coxsackieviruses, and others. Another 20% to 30% of upper infections are caused by bacteria. Bacterial infection can be directly infected or secondary to viral infection. Hemolytic streptococcus is the most common, followed by Haemophilus influenzae, pneumococcus, staphylococcus, etc...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/886A61K36/896A61K9/14A61P11/00
CPCA61K35/618A61K9/0014A61K9/14A61K33/04A61K33/28A61K33/38A61K36/886A61K36/896
Inventor 徐会作
Owner 徐会作
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap